1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: SENORX-S07-002, NCT00699101
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: S07-002, 1098558, NCT00882596
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1098987, NCT00882089
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 40 to 70
Sponsor: Other
Protocol IDs: CRUK-IBIS-II-DCIS, EU-20226, BIG-5-02, NCT00072462, IBCSG-31-03-DCIS, ISRCTN31488319
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCT00103181
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 96/84 Graham, NCT00138814
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: OCOG-2005-RAPID, CIHR Grant Number: MCT-78567, NCT00282035
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: GEC-ESTRO APBI Trial, NCT00402519
|
|
9.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TROG 07.01, NHMRC 454390, NCT00470236
|
|
10.
|
Phase: Phase III
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: SU-12102007-930, 98272, BRSNSTU0025, NCT00695916, NCT00695916
|
|
11.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-43, NSABP-B-43, NCT00769379
|
|
12.
|
Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4126, NCT00757302
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INCA-BONBIS, BONBIS, RECF0911, VA-2008/25, ID-RCB-2008-A00494-51, NCT00907868
|
|
14.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: MDA-P50-CA-58183, H-19895, BCM-H-19895, BCM-P50-CA-58183, NCT00555152
|
|
15.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: UPCC-15107, UPCC-15107, 807010, NCT00923143
|
|
16.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: Adult
Sponsor: NCI
Protocol IDs: UMN-2008NTLS083, 2008NTLS083, NCT01009437
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMN-2002LS097, UMN-0211M35761, NCT00290654
|
|
18.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCI 03-16, NCT00256217
|
|
19.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: UCSF-047522, UCSF-H8409-26206-01, MSKCC-06041, NCT00416403
|
|
20.
|
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 1B-06-9, NCT00556907
|
|
21.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 21
Sponsor: NCI
Protocol IDs: OHSU-3872, 3872, OHSU-CTRC-1037, NCT00627276
|
|
22.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: 200211003, NCT00583700
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 0601000957, NCT00611624
|
|
24.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCCI 07-001.1, NCT00631852
|
|
25.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DCIS-WHM-703M, NCT00669747
|
